Semeraro F - Search Results

1

Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy.

Macor P, Durigutto P, Argenziano M, Smith-Jackson K, Capolla S, Di Leonardo V, Marchbank K, Tolva VS, Semeraro F, Ammollo CT, Colucci M, Cavalli R, Meroni P, Tedesco F. Macor P, et al. Among authors: semeraro f. Haematologica. 2023 Jul 1;108(7):1861-1872. doi: 10.3324/haematol.2022.281505. Haematologica. 2023. PMID: 36172817 Free PMC article.

2

Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins.

Semeraro F, Ammollo CT, Semeraro N, Colucci M. Semeraro F, et al. Among authors: semeraro n. Haematologica. 2009 Jun;94(6):819-26. doi: 10.3324/haematol.2008.000042. Epub 2009 Apr 18. Haematologica. 2009. PMID: 19377079 Free PMC article.

3

Extracellular histones promote fibrinolysis by single-chain urokinase-type plasminogen activator in a factor seven activating protease-dependent way.

Semeraro F, Ammollo CT, Semeraro N, Colucci M. Semeraro F, et al. Among authors: semeraro n. Thromb Res. 2020 Dec;196:193-199. doi: 10.1016/j.thromres.2020.08.034. Epub 2020 Aug 23. Thromb Res. 2020. PMID: 32891905

4

Monoclonal antibodies targeting the antifibrinolytic activity of activated thrombin-activatable fibrinolysis inhibitor but not the anti-inflammatory activity on osteopontin and C5a.

Semeraro F, Ammollo CT, Gils A, Declerck PJ, Colucci M. Semeraro F, et al. J Thromb Haemost. 2013 Dec;11(12):2137-47. doi: 10.1111/jth.12431. J Thromb Haemost. 2013. PMID: 24134522 Free article.

5

Coagulopathy of Acute Sepsis.

Semeraro N, Ammollo CT, Semeraro F, Colucci M. Semeraro N, et al. Among authors: semeraro f. Semin Thromb Hemost. 2015 Sep;41(6):650-8. doi: 10.1055/s-0035-1556730. Epub 2015 Aug 25. Semin Thromb Hemost. 2015. PMID: 26305237 Review.

6

The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood.

Carrieri C, Galasso R, Semeraro F, Ammollo CT, Semeraro N, Colucci M. Carrieri C, et al. Among authors: semeraro n, semeraro f. J Thromb Haemost. 2011 Jan;9(1):154-62. doi: 10.1111/j.1538-7836.2010.04120.x. J Thromb Haemost. 2011. PMID: 20961395 Free article.

7

Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.

Semeraro N, Ammollo CT, Semeraro F, Colucci M. Semeraro N, et al. Among authors: semeraro f. Mediterr J Hematol Infect Dis. 2010 Aug 13;2(3):e2010024. doi: 10.4084/MJHID.2010.024. Mediterr J Hematol Infect Dis. 2010. PMID: 21415977 Free PMC article.

8

Sepsis, thrombosis and organ dysfunction.

Semeraro N, Ammollo CT, Semeraro F, Colucci M. Semeraro N, et al. Among authors: semeraro f. Thromb Res. 2012 Mar;129(3):290-5. doi: 10.1016/j.thromres.2011.10.013. Epub 2011 Nov 5. Thromb Res. 2012. PMID: 22061311 Review.

9

Histones Differentially Modulate the Anticoagulant and Profibrinolytic Activities of Heparin, Heparin Derivatives, and Dabigatran.

Ammollo CT, Semeraro N, Carratù MR, Colucci M, Semeraro F. Ammollo CT, et al. Among authors: semeraro n, semeraro f. J Pharmacol Exp Ther. 2016 Feb;356(2):305-13. doi: 10.1124/jpet.115.229823. Epub 2015 Nov 17. J Pharmacol Exp Ther. 2016. PMID: 26578266

10

FVIII/VWF complex displays a greater pro-haemostatic activity than FVIII preparations devoid of VWF: Study in plasma and cell-based models.

Ammollo CT, Semeraro F, Vitulli A, Dirienzo L, Mezzasoma AM, Semeraro N, Gresele P, Colucci M. Ammollo CT, et al. Among authors: semeraro n, semeraro f. Haemophilia. 2020 Jul;26(4):e151-e160. doi: 10.1111/hae.14008. Epub 2020 Apr 23. Haemophilia. 2020. PMID: 32325538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

390 results

Search Page